Brazil: ANVISA Issues Updated Guidelines Related to COVID-19 and Clinical Trials

June 25, 2020

On June 15, 2020, Brazil’s National Health Surveillance Agency (Agência Nacional de Vigilância Sanitária (ANVISA)) issued an updated technical note providing guidance to sponsors, centers, and researchers related to clinical research and COVID-19. The note provides additional information related to remote verification of source documents. (Google translation of technical note)

For details on all of Brazil's clinical research regulatory requirements, view the Brazil country profile.